1. Regional differences in naloxone modulation of Δ9-THC-induced Fos expression in rats;Allen;Neuropharmacology,2002
2. Oral and hypothalamic injections of barbiturates, benzodiazepines and cannabinoids and food intake in rats;Anderson-Baker;Pharmacology, Biochemistry, and Behavior,1979
3. Anthenelli, R.M., Despres, J.-P., 2004. Effects of rimonabant in the reduction of major cardiovascular risk factors. Results from the STRATUS-US Trial (Smoking Cessation in Smokers Motivated to Quit) and the RIO-LIPIDS Trial (Weight Reducing and Metabolic Effects in Overweight/Obese Patients with Dyslipidemia). American College of Cardiology Annual Meeting, New Orleans.
4. The distribution of cannabinoid-induced fos expression in rat brain: differences between the Lewis and Wistar strain;Arnold;Brain Research,2001
5. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors;Arnone;Psychopharmacology,1997